From other GLP-1 receptor agonists to next-generation triple agonists, compounded peptides to non-peptide prescription medications, the alternatives range from nearly equivalent to genuinely different approaches
"Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review." American Journal of Sports Medicine , 2025
In most cases, you must have a valid prescription, pay entirely out of pocket, and either be uninsured or choose not to submit the medication through your insurance (including government plans like Medicare or Medicaid)
Your doctor will prescribe or adjust the dose based on your response, age, and overall health
One documented case required a 25% dose reduction after starting semaglutide
None of these technologies has been tested with tirzepatide